Skip to main content

Table 4 Duration of PONV during the first postoperative 48 h

From: Oral mosapride can provide additional anti-emetic efficacy following total joint arthroplasty under general anesthesia: a randomized, double-blinded clinical trial

Duration

Control

(n = 80)

Dexa

(n = 82)

Mosa+Dexa

(n = 78)

p*

p1†

p2†

p3†

<  6 h

18 (22.5%)

12 (14.6%)

7 (9.0%)

0.061

   

6–12 h

8 (10.0%)

6 (7.3%)

1 (1.3%)

0.068

   

12–24 h

8 (10.0%)

2 (2.4%)

0

0.004

0.046

0.007

0.497

>  24 h

10 (12.5%)

1 (1.2%)

0

<  0.001

0.004

0.001

1.000

  1. Data presented as number of patients (percentage)
  2. * Uncorrected values
  3. † Bonferroni-corrected p values: p1, Control vs Dexa; p2, Control vs. Mosa+Dexa; p3, Dexa vs. Mosa-Dexa. The corrected significance threshold was 0.016
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us